scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0167-8140(03)00192-0 |
P698 | PubMed publication ID | 14643954 |
P2093 | author name string | Knut Lote | |
Tom B Johannesen | |||
Knut Håkon Hole | |||
Hans Henrik Lien | |||
P2860 | cites work | The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology | Q29615701 |
Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineli | Q30660196 | ||
Brain tumor survival: results from the National Cancer Data Base | Q31932199 | ||
Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. | Q32157803 | ||
Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis | Q33270967 | ||
Neuropsychological function in adults after high dose fractionated radiation therapy of skull base tumors | Q33278948 | ||
Secondary intracranial meningiomas after high-dose cranial irradiation: report of five cases and review of the literature | Q33989961 | ||
Lacunar strokes and infarcts: a review | Q34056829 | ||
Radiation response of the central nervous system | Q34305582 | ||
Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma | Q35821597 | ||
Late deaths and survival after childhood cancer: implications for cure | Q36886494 | ||
The morphologic effects of radiation administered therapeutically for intracranial gliomas.A Postmortem study of 25 cases | Q39811839 | ||
Therapeutic irradiation and brain injury | Q40298944 | ||
Chronic neuroendocrinological sequelae of radiation therapy | Q40505472 | ||
Silent lacunar lesions detected by magnetic resonance imaging of children with brain tumors: a late sequela of therapy | Q40778441 | ||
The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires | Q40950480 | ||
Late radiation injury following hyperfractionated craniospinal radiotherapy for primitive neuroectodermal tumor | Q41648325 | ||
Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis | Q41703759 | ||
Radiation effects on cerebral white matter: MR evaluation | Q42521058 | ||
Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors | Q48278329 | ||
Three-dimensional fast fluid attenuated inversion recovery (3D fast FLAIR): a new MRI sequence which increases the detectable cerebral lesion load in multiple sclerosis | Q48342819 | ||
Hypothalamic-pituitary dysfunction after radiation for brain tumors | Q48346818 | ||
Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma | Q48568497 | ||
Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: A prospective study. | Q50500101 | ||
A prospective longitudinal study on radiation-induced hearing loss. | Q50522854 | ||
Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ=C30 (+ 3). | Q50901825 | ||
Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. | Q51074035 | ||
Adverse effects of brain irradiation correlated with MR and CT imaging. | Q52069587 | ||
Tolerance of the mature human central nervous system to photon irradiation | Q52435067 | ||
Late radiation injury to the temporal lobes: morphologic evaluation at MR imaging. | Q52537174 | ||
Brain tolerance unit: a method to estimate risk of radiation brain injury for various dose schedules. | Q53836582 | ||
A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma | Q55483561 | ||
Cerebral radionecrosis: Incidence and risk in relation to dose, time, fractionation and volume | Q55490446 | ||
Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries | Q58006773 | ||
Malignant tumors of the nasal cavity and ethmoid and sphenoid sinuses | Q68249477 | ||
Magnetic resonance imaging of cranial radiation lesions | Q69060400 | ||
White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02) | Q72789418 | ||
Radiation-induced temporal lobe changes: CT and MR imaging characteristics | Q74071131 | ||
Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study | Q74120490 | ||
P433 | issue | 2 | |
P921 | main subject | adaptive radiation therapy | Q180507 |
P304 | page(s) | 169-176 | |
P577 | publication date | 2003-11-01 | |
P1433 | published in | Radiotherapy and Oncology | Q14251029 |
P1476 | title | Radiological and clinical assessment of long-term brain tumour survivors after radiotherapy | |
P478 | volume | 69 |
Q36288212 | A radiotherapy technique to limit dose to neural progenitor cell niches without compromising tumor coverage |
Q35173719 | AT1 receptor antagonism does not influence early radiation-induced changes in microglial activation or neurogenesis in the normal rat brain |
Q36498995 | Aging-dependent changes in the radiation response of the adult rat brain. |
Q48432887 | An experimental study of acute radiation-induced cognitive dysfunction in a young rat model |
Q91924651 | Are hypothalamic- pituitary (HP) axis deficiencies after whole brain radiotherapy (WBRT) of relevance for adult cancer patients? - a systematic review of the literature |
Q36627154 | Association between radiation dose to neuronal progenitor cell niches and temporal lobes and performance on neuropsychological testing in children: a prospective study |
Q89124703 | Association of Neuronal Injury in the Genu and Body of Corpus Callosum After Cranial Irradiation in Children With Impaired Cognitive Control: A Prospective Study |
Q97644146 | Biomarkers of Brain Damage Induced by Radiotherapy |
Q31154294 | Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas |
Q35196741 | Comparison of dose distributions hippocampus in high grade gliomas irradiation with linac-based imrt and volumetric arc therapy: a dosimetric study |
Q34108267 | Differential effects of radiation and age on diffusion tensor imaging in rats |
Q49504058 | Dosimetric Study and Neurocognitive Function of Hippocampal-Sparing Whole-Brain Radiotherapy |
Q34080378 | Early-delayed, radiation-induced cognitive deficits in adult rats are heterogeneous and age-dependent |
Q33608959 | Effects of the AT1 receptor antagonist L-158,809 on microglia and neurogenesis after fractionated whole-brain irradiation |
Q35201225 | Executive dysfunction in delayed radiation-induced leukoencephalopathy |
Q33667022 | Factors impacting volumetric white matter changes following whole brain radiation therapy |
Q48896559 | Fractionated radiation-induced acute encephalopathy in a young rat model: cognitive dysfunction and histologic findings |
Q33585529 | Hippocampal neuron number is unchanged 1 year after fractionated whole-brain irradiation at middle age. |
Q37244189 | Hippocampal sparing radiotherapy for glioblastoma patients: a planning study using volumetric modulated arc therapy |
Q36604488 | Hippocampal volumes in patients exposed to low-dose radiation to the basal brain. A case-control study in long-term survivors from cancer in the head and neck region. |
Q55461687 | IMRT or 3D-CRT in glioblastoma? A dosimetric criterion for patient selection. |
Q37070104 | Imaging radiation-induced normal tissue injury |
Q39350891 | Infiltration of glioma cells in brain parenchyma stimulated by radiation in the F98/Fischer rat model |
Q48126047 | Intensity modulated radiation therapy versus three-dimensional conformal radiation therapy for the treatment of high grade glioma: a dosimetric comparison |
Q37268523 | Ion mobility-enhanced MS(E)-based label-free analysis reveals effects of low-dose radiation post contextual fear conditioning training on the mouse hippocampal proteome. |
Q89919700 | Ionizing radiation modulates vascular endothelial growth factor expression through STAT3 signaling pathway in rat neonatal primary astrocyte cultures |
Q41220204 | Leukoencephalopathy in long term brain metastases survivors treated with radiosurgery |
Q35760314 | MR Imaging Evaluation of Intracerebral Hemorrhages and T2 Hyperintense White Matter Lesions Appearing after Radiation Therapy in Adult Patients with Primary Brain Tumors |
Q48598891 | MR imaging of late radiation therapy- and chemotherapy-induced injury: a pictorial essay |
Q33430676 | MR spectroscopy in radiation injury. |
Q38648782 | Molecular, Cellular and Functional Effects of Radiation-Induced Brain Injury: A Review |
Q41365419 | Neurocognitive sparing of desktop microbeam irradiation |
Q36137870 | Normal tissue protection for improving radiotherapy: Where are the Gaps? |
Q39386442 | PPARδ prevents radiation-induced proinflammatory responses in microglia via transrepression of NF-κB and inhibition of the PKCα/MEK1/2/ERK1/2/AP-1 pathway |
Q40392408 | Pituitary dysfunction following cranial radiotherapy for adult-onset nonpituitary brain tumours |
Q33912364 | Pituitary dysfunction in adult patients after cranial radiotherapy: systematic review and meta-analysis |
Q48129690 | Radiation Toxicity in the Central Nervous System: Mechanisms and Strategies for Injury Reduction |
Q38029608 | Radiation-induced brain injury: A review |
Q36344693 | Radiation-induced cognitive impairment--from bench to bedside |
Q37768187 | Renin-angiotensin system blockers and modulation of radiation-induced brain injury |
Q45066738 | Role of NADPH oxidase in radiation-induced pro-oxidative and pro-inflammatory pathways in mouse brain. |
Q37356420 | Role of PPARs in Radiation-Induced Brain Injury |
Q46678495 | Should we control the pineal status of patients following brain radiotherapy? |
Q92021951 | Sodium butyrate prevents radiation-induced cognitive impairment by restoring pCREB/BDNF expression |
Q48948503 | Sparing of the hippocampus, limbic circuit and neural stem cell compartment during partial brain radiotherapy for glioma: a dosimetric feasibility study |
Q45154827 | Stereotactic radiation therapy for progressive residual pilocytic astrocytomas |
Q41857050 | The PPARδ agonist GW0742 inhibits neuroinflammation, but does not restore neurogenesis or prevent early delayed hippocampal-dependent cognitive impairment after whole-brain irradiation |
Q30835167 | The diagnosis and treatment of pseudoprogression, radiation necrosis and brain tumor recurrence |
Q47109310 | The role of stereotactic radiosurgery and whole brain radiation therapy as primary treatment in the treatment of patients with brain oligometastases - A systematic review |
Q92959304 | Treatment of Radiation-Induced Cognitive Decline in Adult Brain Tumor Patients |
Q37145380 | Whole brain radiation-induced cognitive impairment: pathophysiological mechanisms and therapeutic targets |
Q38150963 | Whole brain radiation-induced vascular cognitive impairment: mechanisms and implications |
Q34347439 | Whole brain radiotherapy for brain metastasis |
Search more.